Completed NA INTERVENTIONAL 2-arm NCT01091506

A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients

Sponsor: Massachusetts General Hospital

Updated 6 times since 2017 Last updated: Aug 2, 2016 Started: Mar 31, 2010 Primary completion: Mar 31, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Schizophrenia, this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 6 data snapshots since 2010. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital
Pamlab, Inc.

Data source: Pamlab, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States